Tenoxicam

DB00469ApprovedInvestigationalSmall molecule

Tenoxicam is an anti inflammatory analgesic used to treat mild to moderate pain as well as the signs and symptoms of rheumatoid arthritis and osteoarthritis. Tenoxicam, an antiinflammatory agent with analgesic and antipyretic properties, is used to treat osteoarthritis and control acute pain.

Chemical structure of Tenoxicam
Mechanism
Curator reviewed
Primary indication
For the treatment of rheumatoid arthritis, osteoarthritis, backache, and pain.Curator reviewed · 4 structured indications
Formula / weight
C13H11N3O4S2 · 337.37 g/mol (avg)
First approval
Canada, 1997
Code names
RO 12-0068

Resolves to

Structure
InChIKeyLZNWYQJJBLGYLT-UHFFFAOYSA-NSMILESCN1C(C(=O)NC2=CC=CC=N2)=C(O)C2=C(C=CS2)S1(=O)=O
Transporters

What you can answer from here — as of September 23, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
1TransporterSubstrate / inhibitor direction, not just membership
Listed above
1,591Drug interactionsStructured to mechanism, not free text
Sign in
20Clinical trialsPhase, status and sponsor resolved per trial
Sign in
4Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
2ContraindicationsEach with its own population and attribute set
Sign in
117Marketed productsAcross 8 countries and 72 labellers
Sign in
1ATC codeIncluding every combination product, plus 24 drug categories
Sign in
16+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Tenoxicam, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account